UNSPSC 51262702: Tymazoline

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C14H20N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U993RH5585, chemically known as 1,4,5-dihydro-2-(2-isopropyl-5-methylphenoxymethyl)imidazol but generally known as tymazoline, which bears US NIH Compound Identifier 34154. European Medicines Agency schedules Tymazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15640MIG.

World Health Organization schedules tymazoline in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, TYMAZOLINE remains the US FDA Preferred Term for this commodity. Tymazoline bears US NLM identifiers UMLS ID C0771442 and NCI Concept Code C95309. SMILES: O(C1C(C(C)C)CCC(C1)C)CC1=NCCN1.

UNSPSC 51262702 Tymazoline, a Commodity code, nominally encompasses pharmaceutical nasal decongestants, but recent state and local procurement activity under this code shows minimal direct alignment with the code's product name. The single recent opportunity on record — Seminole County, Florida's IFB60459723LAS for Naloxone and Safe Drug Deactivation Systems — targets opioid-overdose reversal and controlled-substance disposal equipment rather than tymazoline products. The county is seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must include all shipping and delivery costs in their bids, submit electronically through the county's e-Procurement Portal, maintain workers' compensation and commercial general liability insurance, and comply with E-Verify and drug-free workplace certification requirements. The contract carries an initial two-year term with an optional one-year renewal and includes a three-month probationary period allowing termination by the county with or without cause. FEMA potentially funds the procurement, imposing additional federal compliance obligations including adherence to the Clean Air Act and Federal Water Pollution Control Act.

Geographic activity under this Commodity code is limited to Florida based on the available record. Seminole County is the sole issuing body shown in recent opportunities. The IFB60459723LAS originally posted June 30, 2026, with a response deadline of July 26, 2023 — a date conflict in the source material that suggests data quality issues in the underlying record. The mismatch between the code's nominal scope (tymazoline) and the actual procurement (naloxone and drug deactivation systems) indicates this code may not be capturing tymazoline purchases effectively, or that state and local procurement offices are applying the code inconsistently to pharmaceutical and medical-device acquisitions. Firms pursuing opioid-response or substance-abuse-prevention equipment should verify code alignment with issuing bodies before submitting proposals.